SAN FRANCISCO, Oct. 23 – Cepheid on Tuesday posted third-quarter revenues of $2.8 million versus $2.3 for the same quarter a year ago, the company announced.

For the nine months ending September 30, 2001, revenue jumped 85 percent to $8.1 million compared to $4.4 million for the same period in 2000.

The company said the revenue increase was due to increased sales of its Smart Cycler DNA analysis systems, with sales increasing to $2 million from $1.6 million for the same quarter in 2000.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.